港股異動丨中國投資基金(0612.HK)大漲超11% 配售4000萬股 籌資1.18億
格隆匯5月17日丨中國投資基金(0612.HK)快速拉昇漲11.4%,報4.2港元,總市值57億港元。公司昨晚公吿,配售最多4000萬股新股,相當於擴大後股本2.87%;配售價3.05港元,較上交易日(16日)收報折讓19.10%。集資總額1.22億港元,所得淨額1.18億港元。董事認為,建議配售事項乃公司籌集資金,以加強其資本基礎(包括營運資金)及改善財務狀況的良機,可令公司更好地投資上市及非上市證券。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.